Table 4.
Outcome Measures for Patients with POAF with RVR in the SICU
| N = 27 median [intraquartile range] or n (%) |
|
|---|---|
| Medication used at 7 day following diagnosis or discharge if before 7 days (n=27, 6 died before day 7) | |
| None | 2 (7) |
| Beta blocker | 17 (63) |
| Calcium channel blocker | 1 (4) |
| Amiodarone | 5 (19) |
| Digoxin | 0 |
| Amiodarone and Beta blocker | 1 (4) |
| Digoxin, Beta blocker, and calcium channel blocker | 1 (4) |
| Anticoagulation used at 7 days following diagnosis or discharge if before 7 days | |
| None | 18 (54) |
| Warfarin | 4 (12) |
| Rivaroxaban | 1 (3) |
| Dabigatran | 1 (3) |
| Heparin | 9 (27) |
| Hospital length of stay | 13 [8, 22] |
| SICU length of stay | 7 [5, 18] |
| ICU Scoring System | |
| APACHE II | 14 [10, 18] |
| SOFA | 4 [3, 6] |
| SAPS II | 32 [21, 36] |
| ICU readmission after AF treatment | 3 (9) |
| Readmission to SICU for recurrent AF | 2 (6) |
| 30 day readmission (n = 26) | 8 (31) |
| 30 day ED visit (n = 18) | 1 (6) |
| Discharge Disposition | |
| Home / home health service | 15 (45) |
| Dead | 7 (21) |
| Skilled Nursing Facility/ Inpatient Rehabilitation | 6 (18) |
| Long Term Acute Care Center | 3 (9) |
| Transfer to other hospital | 2 (6) |
| Rate/Rhythm controlled at 48 hours from AF onset | 26 (79) |
| Rate controlled at discharge/death | 31 (94) |
| Rhythm controlled at discharge/death | 27 (82) |
| Primary Care physician follow-up (n = 26) | 10 (38) |
| Cardiology follow-up scheduled (n = 26) | 6 (23) |